# Xtant Medical Holdings, Inc.: Form 10-Q for the period ended Sep 30, 2013

- Company: [Xtant Medical Holdings, Inc.](/companies/xtnt.md) (CIK 1453593)
- Form: 10-Q
- Filed: 2013-11-14
- Accepted by EDGAR: Nov 14, 2013, 16:22 ET
- Period: 2013-09-30
- Accession: 0001144204-13-061887
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1453593/000114420413061887/v359011_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1453593/000114420413061887/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-07-01 to 2013-09-30 | $10.5m | us-gaap:Revenues |
| Revenue | 9 months, 2013-01-01 to 2013-09-30 | $24.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2013-07-01 to 2013-09-30 | $3.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2013-01-01 to 2013-09-30 | $10.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2013-07-01 to 2013-09-30 | $4.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2013-01-01 to 2013-09-30 | $14.8m | us-gaap:GrossProfit |
| Operating income | 3 months, 2013-07-01 to 2013-09-30 | −$2.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2013-01-01 to 2013-09-30 | −$5.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2013-07-01 to 2013-09-30 | $1.2m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2013-01-01 to 2013-09-30 | $3.4m | us-gaap:InterestExpense |
| Net income | 3 months, 2013-07-01 to 2013-09-30 | −$4.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2013-01-01 to 2013-09-30 | −$8.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-07-01 to 2013-09-30 | −$0.08 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2013-01-01 to 2013-09-30 | −$0.18 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-07-01 to 2013-09-30 | −$0.08 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2013-01-01 to 2013-09-30 | −$0.18 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-07-01 to 2013-09-30 | 51,616,319 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2013-01-01 to 2013-09-30 | 46,611,358 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2013-01-01 to 2013-09-30 | −$5.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2013-01-01 to 2013-09-30 | $633.4k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2013-09-30 | $3.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-09-30 | $21.8m | us-gaap:AssetsCurrent |
| Total assets | at 2013-09-30 | $31.0m | us-gaap:Assets |
| Current liabilities | at 2013-09-30 | $8.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-09-30 | $31.7m | us-gaap:Liabilities |
| Long-term debt | at 2013-09-30 | $16.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2013-09-30 | $47.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2013-09-30 | −$636.0k | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1453593/000114420413061887/v359011_10q.htm

Filed Nov 14, 2013.
Source: SEC EDGAR, the filing index for accession 0001144204-13-061887. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.
